These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17542446)

  • 1. Texas statewide hepatitis C counseling and testing, 2000-2005.
    Heseltine G; McFarlane J
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):6-11. PubMed ID: 17542446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a viral hepatitis prevention and control program: Florida's experience.
    Baldy LM; Urbas C; Harris JL; Jones TS; Reichert PE
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):24-30. PubMed ID: 17542449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates.
    Stopka TJ; Marshall C; Bluthenthal RN; Webb DS; Truax SR
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):68-73. PubMed ID: 17542457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado.
    Subiadur J; Harris JL; Rietmeijer CA
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):12-7. PubMed ID: 17542447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005.
    Zimmerman R; Finley C; Rabins C; McMahon K
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):18-23. PubMed ID: 17542448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care?
    Hennessy RR; Weisfuse IB; Schlanger K
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):31-5. PubMed ID: 17542450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs and impacts of testing for hepatitis C virus antibody in public STD clinics.
    Honeycutt AA; Harris JL; Khavjou O; Buffington J; Jones TS; Rein DB
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):55-62. PubMed ID: 17542455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C: a public health response in Kansas.
    Taylor C; Waters K
    Kans Nurse; 2004 Apr; 79(4):8-9. PubMed ID: 16381345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs.
    Buffington J; Murray PJ; Schlanger K; Shih L; Badsgard T; Hennessy RR; Wood R; Weisfuse IB; Gunn RA
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):63-7. PubMed ID: 17542456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis C virus infection among clients of HIV counseling and testing sites--Connecticut, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jul; 50(27):577-81. PubMed ID: 11475165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services' sexually transmitted disease clinics.
    D'Souza G; Arafat R; Hwang L; Cunningham C; Shah S; Reynolds K
    J Viral Hepat; 2003 Mar; 10(2):134-40. PubMed ID: 12614470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
    Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
    Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users].
    Gyarmathy VA; Rácz J
    Orv Hetil; 2011 Jan; 152(4):124-30. PubMed ID: 21224188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing integration of HIV, STD, and viral hepatitis services: state perspectives.
    Whiticar P; Liberti T
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):91-5. PubMed ID: 17542462
    [No Abstract]   [Full Text] [Related]  

  • 18. An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus.
    Irvin R; McAdams-Mahmoud A; White JJ; Grant Z; Falade-Nwulia O; Sherman SG; Beyrer C; Sulkowski MS; Thomas DL; Mehta SH; Chaisson RE
    Prog Community Health Partnersh; 2018; 12(1):101-109. PubMed ID: 29606698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
    Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA
    Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S276-85. PubMed ID: 15768335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Hepatitis C Testing and Linkage to Care at a Local Health Department Sexually Transmitted Disease Clinic: Determining Essential Resources and Evaluating Outcomes.
    Rhea S; Seña AC; Hilton A; Hurt CB; Wohl D; Fleischauer A
    Sex Transm Dis; 2018 Apr; 45(4):229-232. PubMed ID: 29465696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.